UnitedHealth Group said it established a new Public Responsibility Committee on its board of directors, which will monitor and oversee financial, regulatory, and reputational risks that may affect the company's operations and mission.

1. 01

   UnitedHealth Group said it established a new Public Responsibility Committee on its board of directors, which will monitor and oversee financial, regulatory, and reputational risks that may affect the company's operations and mission.

2. 02

   The company cited underwriting and forecasting, regulatory relationships, reputational matters, and mergers and acquisitions as core oversight responsibilities of the committee, and said Michele Hooper will serve as chair, with Charles Baker, Timothy Flynn and Paul Garcia serving as members.

3. 03

   UnitedHealth Group said it appointed F. William McNabb as lead independent director, replacing Michele Hooper, who will continue to serve as a director. The company explained that McNabb has served on the board of directors since 2018 and previously served as chairman and chief executive officer of the Vanguard Group.

4. 04

   The company said it refreshed the leadership and composition of its four existing committees. Timothy Flynn chairs the Audit and Finance Committee, Paul Garcia chairs the Compensation and Human Resources Committee, Charles Baker chairs the Governance Committee, and Valerie Montgomery Rice, M.D. chairs the Health and Clinical Practice Policies Committee.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.